RxDoctor Payments Data

Rizwan Akhtar, MD

Neurology · Chicago, ILNPI 1770786865

Payments from drug & device makers

What this record shows

That places this record below the midpoint for neurology clinicians in IL, where the typical reported total is $547.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$211,075in research payments, 2019–2025

Across 13 payments — averaging $16,237 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • UCB SA$211K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois

Medicare billing

Part B allowed, 2024
$77,601
Medicare patients
244
Services billed
2,255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rasagiline Mesylate46$6,430
Carbidopa-LevodopaCarbidopa/Levodopa166$5,190
AmantadineAmantadine Hcl16$2,155
Carbidopa-Levodopa ErCarbidopa/Levodopa50$1,405
Primidone34$789
Propranolol Hcl23$548
Memantine Hcl14$376
Pramipexole DihydrochloridePramipexole Di-Hcl13$272
Gabapentin14$200
Donepezil Hcl13$188
Quetiapine Fumarate15$75

Paid to pharmacies, not to this prescriber.

Other neurology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →